SGLT2 inhibition in the management of type 2 diabetes: Potential impact on CVD RiskSep. 2, 2015
Teaching slides prepared and presented by Prof. Silvio E Inzucchi, New Haven, CT, USA at EBAC accredited symposium 'Managing Diabetes & CVD: Exploring new evidence and opportunities' at ESC 2015 in London.
Download presentation in PDFLecture 3 prof Inzucchi SGLT2 inhibition in the management of type 2 diabetes.pdf (2,5MB)
Click on images to view presentation